Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dement...

by Kandiah N, Pai MC, Senanarong V, Looi I, Ampil E, Park KW, Karanam AK, Christopher S
Published 2017-04-01

Real-world evaluation of compliance and preference in Alzheimer’s disease treatment: an observational study in Taiwan 

by Lai TH, Wang WF, Yip BS, Yang YW, Peng GS, Tsai SJ, Liao YC, Pai MC
Published 2016-03-01

Real-world evaluation of compliance and preference in Alzheimer’s disease treatment

by Pai MC, Aref H, Bassil N, Kandiah N, Lee JH, Srinivasan AV, diTommaso S, Yuksel O
Published 2015-11-01